This year’s CPhI Worldwide pharma event taking place in Madrid (9-11, October 2018) and organized by UBM (part of Informa plc) will feature expert panel discussions moderated by Fiona Barry and Peter Shapiro, Editors at PharmSource, a GlobalData company.
Fiona Barry, Editor at PharmSource a GlobalData Company
Fiona will be leading a lively discussion at the CPhI Worldwide Media Debate on the year’s most influential trends in pharma with contributors to the CPhI Annual Report including Vivek Shah, CEO of Piramal Pharma Solutions, and Dawn Ecker, Consultant at BioProcess Technology Consultants. This will take place on Tuesday, October 9 at 11:30am in Room 111 (near the south entrance).
The PharmaSource editor provided a number of key insights in the CPhI Annual Report 2018, predicting that many CMOs will be hit hard by the proposed production cut of opioid compounds by the DEA to combat the opioid addiction crisis. Conversely, she also predicted that the development of non-opioid painkillers could be a possible replacement revenue stream and will become a profitable opportunity for CMOs and drug companies in the near future.
Fiona commented, “Out of the 30 CMOs involved in commercial drug manufacture using controlled substances, 18 (60%) produce opioids. While contractors involved in controlled substance production constitute a minority of US CMO facilities, it is clear that they will be hit particularly hard by the reduced volumes of opioid manufacturing. The ever-growing number of opioid lawsuits—such as the US state lawsuits against Purdue Pharma—is likely to deter pharma companies from producing and outsourcing these products in the future.
“However, opportunities for CMOs and drug companies relating to non-opioid painkiller manufacture are likely to become more lucrative in the future, as alternatives to addictive opioids are sought.”
Peter Shapiro, Editor at PharmSource a GlobalData Company
Peter Shapiro will be headlining at bioLIVE, the large molecule biopharma manufacturing and processing event running adjacent to CPhI, for an expert panel on Cell and Gene Therapies. His event will take place on Wednesday, October 10 at 15:15 to 16:45 in the bioLIVE Content Dome in Hall 12.
Peter will be joined by Dan Leorda, VP, Business Development – Biologics at Integrated Project Services (IPS); Peter Makowenskyj, Sales Engineer at G-Con Manufacturing; and Philip Ridley-Smith, Sales and Marketing Director at Cobra Biologics.
Other conference highlights will include PharmSource founder and former President Jim Miller’s keynote talk “What ifs” in the 5-year CDMO plan and the M&A Outlook Pharma panel discussion.